- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- May 2024
- 131 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- December 2023
- 180 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- July 2018
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- August 2022
Global
From €754EUR$790USD£632GBP
The Anaphylaxis Drug market is a subset of the Immune Disorders Drugs market, which focuses on the treatment of anaphylaxis, a severe allergic reaction. Anaphylaxis is a life-threatening condition that requires immediate medical attention. Anaphylaxis drugs are used to treat the symptoms of anaphylaxis, such as swelling, hives, and difficulty breathing. These drugs can be administered orally, intravenously, or intramuscularly. Common anaphylaxis drugs include epinephrine, antihistamines, and corticosteroids.
Anaphylaxis drugs are used to treat a wide range of allergic reactions, including food allergies, insect stings, and drug allergies. These drugs are also used to treat asthma, which is a chronic condition that can cause anaphylaxis. Anaphylaxis drugs are available in both prescription and over-the-counter forms.
Some companies in the Anaphylaxis Drug market include Sanofi, Mylan, Teva Pharmaceuticals, and Pfizer. These companies produce a variety of anaphylaxis drugs, including epinephrine auto-injectors, antihistamines, and corticosteroids. Show Less Read more